PTAB Won't Review 2 More HHS HIV-Prevention Patents
The federal government has scored another victory in its dispute with Gilead Sciences Inc. over HIV-prevention patents after the Patent Trial and Appeal Board refused to take up the drugmaker's challenges...To view the full article, register now.
Already a subscriber? Click here to view full article